FB
NASDAQ · FBIOP
Fortress Biotech, Inc.
Healthcare · Biotechnology
$18.44
Up+$0.12 (+0.66%)
Updated Sep 15, 2026, 11:18 AM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 60.62M
- P/E ratio
- 11.44
- Dividend yield
- 0.00%
- 52-week range
- $12.50 – $21.43
- Volume
- 1.31K
- Avg. volume
- 15.83K
Price performance
FBIOP price history
1M range · 20 trading sessions · Daily adjusted prices
FBIOP closed at $18.44 after 20 trading sessions, up 1.71% for the selected period.
- Last close
- $18.44
- Period change
- +1.71%
- Period low
- $18.13
- Period high
- $18.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $18.45 | $18.45 | $18.44 | $18.44 | 1.31K |
| Sep 11, 2026 | $18.70 | $18.755 | $18.32 | $18.45 | 3.63K |
| Sep 10, 2026 | $18.545 | $18.59 | $18.50 | $18.575 | 8.86K |
| Sep 9, 2026 | $18.50 | $18.60 | $18.49 | $18.59 | 10.12K |
| Sep 8, 2026 | $18.75 | $18.75 | $18.5404 | $18.65 | 3.52K |
| Sep 4, 2026 | $18.55 | $18.80 | $18.54 | $18.75 | 7.84K |
| Sep 3, 2026 | $18.73 | $18.73 | $18.51 | $18.56 | 3.6K |
| Sep 2, 2026 | $18.60 | $18.80 | $18.55 | $18.72 | 7.14K |
| Sep 1, 2026 | $18.55 | $18.60 | $18.50 | $18.50 | 4.58K |
| Aug 31, 2026 | $18.68 | $18.82 | $18.5459 | $18.73 | 3.04K |
| Aug 28, 2026 | $18.75 | $18.75 | $18.50 | $18.61 | 5.09K |
| Aug 27, 2026 | $18.375 | $18.575 | $18.375 | $18.56 | 6.63K |
| Aug 26, 2026 | $18.21 | $18.43 | $18.00 | $18.40 | 4.98K |
| Aug 25, 2026 | $18.36 | $18.40 | $18.2001 | $18.30 | 17.06K |
| Aug 24, 2026 | $18.498 | $18.498 | $18.1501 | $18.39 | 13.35K |
| Aug 21, 2026 | $18.30 | $18.59 | $18.30 | $18.3001 | 8.5K |
| Aug 20, 2026 | $18.023 | $18.27 | $18.023 | $18.27 | 11.63K |
| Aug 19, 2026 | $18.16 | $18.3399 | $18.05 | $18.205 | 12.26K |
| Aug 18, 2026 | $18.0501 | $18.26 | $18.00 | $18.22 | 10.77K |
| Aug 17, 2026 | $18.53 | $18.55 | $18.08 | $18.13 | 17.63K |
Latest FBIOP news
The latest Smart Investors Daily articles mentioning FBIOP.
Stock researchResearch & News · Analysis
Loading stock research…
